ACTH Treatment of APOL1- Associated Nephropathy

Trial Profile

ACTH Treatment of APOL1- Associated Nephropathy

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Kidney disorders; Proteinuria
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Apr 2016 Status changed from recruiting to withdrawn prior to enrolment due to no enrolment occurred.
    • 10 Dec 2014 Status changed from not yet recruiting to recruiting as reported by record.
    • 21 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top